{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:45:32Z","timestamp":1790372732236,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cca.2020.03.016","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T04:12:10Z","timestamp":1583727130000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["High risk screening for Gaucher disease in patients with splenomegaly and\/or thrombocytopenia in China: 55 cases identified"],"prefix":"10.1016","volume":"506","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7527-3754","authenticated-orcid":false,"given":"Yonglan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-1803","authenticated-orcid":false,"given":"Chunhua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.03.016_b0005","doi-asserted-by":"crossref","unstructured":"J. Stirnemann, N. Belmatoug, F. Camou, et al., A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments, Int. J. Molecul. Sci. 18 (2017). https:\/\/ doi: 10.3390\/ijms18020441.","DOI":"10.3390\/ijms18020441"},{"key":"10.1016\/j.cca.2020.03.016_b0010","doi-asserted-by":"crossref","unstructured":"A.H. Charrow J1, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A, The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease, Arch. Int. Med. 160 (2000) 2835-2843. https:\/\/ doi: 10.1001\/archinte.160.18.2835.","DOI":"10.1001\/archinte.160.18.2835"},{"key":"10.1016\/j.cca.2020.03.016_b0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/jhg.2017.36","article-title":"Successful newborn screening for Gaucher disease using fluorometric assay in China","author":"Kang","year":"2017","journal-title":"J Hum Genet. 62"},{"key":"10.1016\/j.cca.2020.03.016_b0020","doi-asserted-by":"crossref","unstructured":"Y. Feng, Y. Huang, C. Tang, et al., Clinical and molecular characteristics of patients with Gaucher disease in Southern China, Blood cells, Molecul. Dis. 68 (2018) 30-34. https:\/\/ doi: 10.1016\/j.bcmd.2016.10.026.","DOI":"10.1016\/j.bcmd.2016.10.026"},{"key":"10.1016\/j.cca.2020.03.016_b0025","doi-asserted-by":"crossref","unstructured":"v.W.S. Hollak CE, van Oers MH, Aerts JM, Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease, J. Clin. Invest. 93 (1994) 1288-1292. https:\/\/ doi: 10.1172\/JCI117084.","DOI":"10.1172\/JCI117084"},{"key":"10.1016\/j.cca.2020.03.016_b0030","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.clinbiochem.2013.09.006","article-title":"Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring","volume":"46","author":"Irun","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2020.03.016_b0035","doi-asserted-by":"crossref","unstructured":"N. Hurvitz, T. Dinur, M. Becker-Cohen, et al., Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease, International journal of molecular sciences. 20 (2019). https:\/\/ doi: 10.3390\/ijms20123033.","DOI":"10.3390\/ijms20123033"},{"key":"10.1016\/j.cca.2020.03.016_b0040","doi-asserted-by":"crossref","unstructured":"A. Uribe, R. Giugliani, Selective screening for lysosomal storage diseases with dried blood spots collected on filter paper in 4,700 high-risk colombian subjects, JIMD reports. 11 (2013) 107-116. https:\/\/ doi: 10.1007\/8904_2013_229.","DOI":"10.1007\/8904_2013_229"},{"key":"10.1016\/j.cca.2020.03.016_b0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s10038-018-0438-7","article-title":"High-risk screening for Gaucher disease in patients with neurological symptoms","volume":"63","author":"Momosaki","year":"2018","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.cca.2020.03.016_b0050","unstructured":"China 2015 expert consensus on Gaucher disease for diagnosis and treatment, Zhonghua Er. Ke. Za. Zhi. 53 (2015) 256-261."},{"key":"10.1016\/j.cca.2020.03.016_b0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2008.08.024","article-title":"An improved high-throughput dried blood spot screening method for Gaucher disease","volume":"398","author":"Olivova","year":"2008","journal-title":"Clin. Chim. Acta: Int. J. Clin. Chem."},{"key":"10.1016\/j.cca.2020.03.016_b0060","series-title":"Laboratory Guide to the Methods in Biochemical Genetics","author":"Blau","year":"2008"},{"key":"10.1016\/j.cca.2020.03.016_b0065","doi-asserted-by":"crossref","unstructured":"L.J.H. Bean, M.R. Hegde, Clinical implications and considerations for evaluation of in silico algorithms for use with ACMG\/AMP clinical variant interpretation guidelines, Genome medicine. 9 (2017) 111. https:\/\/ doi: 10.1186\/s13073-017-0508-z.","DOI":"10.1186\/s13073-017-0508-z"},{"key":"10.1016\/j.cca.2020.03.016_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.01.018","article-title":"Chitotriosidase on treatment-naive patients with Gaucher disease: a genotype vs phenotype study","volume":"492","author":"Sperb-Ludwig","year":"2019","journal-title":"Clin. Chim. Acta: Int. J. Clin. Chem."},{"key":"10.1016\/j.cca.2020.03.016_b0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ejh.12596","article-title":"A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and\/or Thrombocytopenia","volume":"96","author":"Motta","year":"2016","journal-title":"Europ. J. Haematol."},{"key":"10.1016\/j.cca.2020.03.016_b0080","doi-asserted-by":"crossref","unstructured":"K. Lei, Y. Zhao, L. Sun, et al., A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China, Orphanet journal of rare diseases. 13 (2018) 48. https:\/\/ doi: 10.1186\/s13023-018-0782-x.","DOI":"10.1186\/s13023-018-0782-x"},{"key":"10.1016\/j.cca.2020.03.016_b0085","doi-asserted-by":"crossref","unstructured":"A.H. Kaplan P1, Kacena KA, Yee JD, The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis, Arch Pediatr Adolesc Med. 160 (2006) 603-608. https:\/\/ doi: 10.1001\/archpedi.160.6.603.","DOI":"10.1001\/archpedi.160.6.603"},{"key":"10.1016\/j.cca.2020.03.016_b0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2020.03.016_b0095","article-title":"Neurochemical abnormalities in patients with type 1 gaucher disease on standard of care therapy","author":"Kartha","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2020.03.016_b0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.braindev.2018.06.006","article-title":"Genotypes and phenotypes in 20 Chinese patients with type 2 Gaucher disease","volume":"40","author":"Kang","year":"2018","journal-title":"Brain Dev."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:51:21Z","timestamp":1757861481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120301170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":20,"alternative-id":["S0009898120301170"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.03.016","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High risk screening for Gaucher disease in patients with splenomegaly and\/or thrombocytopenia in China: 55 cases identified","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}